Browse by Journal Title

Article

The recurrent atypical e8a2 BCR::ABL1 transcript with insertion of an inverted 55 base pair ABL1 intron 1b sequence: a detailed molecular analysis.
Burmeister, T., Bullinger, L. and le Coutre, P.
Acta Haematologica 146 (5): 413-418. October 2023

Longitudinal study to assess the clinical significance of MSI2 expression in chronic myeloid keukemia patients.
Kaeda, J., Ringel, F., Oberender, C., Gresse, M., Amini, L., Schwarz, M., Doerken, B. and le Coutre, P.
Acta Haematologica 136 (1): 62-64. June 2016

BCR-ABL1 acute myeloid leukemia: clonal selection of a BCR-ABL1(-) subclone as a cause of refractory disease with nilotinib treatment.
Neuendorff, N.R., Schwarz, M., Hemmati, P., Tuerkmen, S., Bommer, C., Burmeister, T., Doerken, B., le Coutre, P., Arnold, R. and Westermann, J.
Acta Haematologica 133 (2): 237-241. 2015

Effects of Jak2 type 1 inhibitors NVP-BSK805 and NVP-BVB808 on Jak2 mutation-positive and Bcr-Abl-positive cell lines.
Ringel, F., Kaeda, J., Schwarz, M., Oberender, C., Grille, P., Doerken, B., Marque, F., Manley, P.W., Radimerski, T. and le Coutre, P.
Acta Haematologica 132 (1): 75-86. 31 January 2014

Reduced-intensity conditioning using fludarabine and antithymocyte globulin alone allows stable engraftment in a patient with Dyskeratosis congenita.
Vuong, L.G., Hemmati, P.G., Neuburger, S., Terwey, T.H., Vulliamy, T., Dokal, I., Le Coutre, P., Doerken, B. and Arnold, R.
Acta Haematologica 124 (4): 200-203. December 2010